U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H26N4O.2C4H4O4
Molecular Weight 534.5589
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of EMEDASTINE DIFUMARATE

SMILES

OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.CCOCCN1C2=CC=CC=C2N=C1N3CCCN(C)CC3

InChI

InChIKey=FWLKKPKZQYVAFR-LVEZLNDCSA-N
InChI=1S/C17H26N4O.2C4H4O4/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20;2*5-3(6)1-2-4(7)8/h4-5,7-8H,3,6,9-14H2,1-2H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1+

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
EMEDASTINE DIFUMARATE
EP   JAN   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF  
USAN  
Official Name English
1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole fumarate (1:2)
Systematic Name English
EMEDASTINE DIFUMARATE [USP-RS]
Common Name English
EMEDASTINE DIFUMARATE [EP MONOGRAPH]
Common Name English
EMEDASTINE DIFUMARATE [USAN]
Common Name English
AL-3432A
Code English
EMEDASTINE DIFUMARATE [VANDF]
Common Name English
Emedastine fumarate [WHO-DD]
Common Name English
LY188695
Common Name English
EMEDASTINE DIFUMARATE [JAN]
Common Name English
LY-188695
Code English
EMEDASTINE DIFUMARATE [USP MONOGRAPH]
Common Name English
EMEDASTINE FUMARATE
MART.   WHO-DD  
Common Name English
EMEDASTINE FUMARATE [MART.]
Common Name English
RAPIMINE
Common Name English
KB-2413
Code English
1H-BENZIMIDAZOLE, 1-(2-ETHOXYETHYL)-2-(HEXAHYDRO-4-METHYL-1H-1,4-DIAZEPIN-1-YL)-, (E)-2-BUTENEDIOATE (1:2)
Systematic Name English
EMEDASTINE DIFUMARATE [ORANGE BOOK]
Common Name English
EMEDASTINE DIFUMARATE [USP IMPURITY]
Common Name English
EMADINE
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C29578
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
EMA ASSESSMENT REPORTS EMADINE (AUTHORIZED: CONJUNCTIVIS, ALLERGIC)
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
Code System Code Type Description
FDA UNII
42MB94QOSM
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
PUBCHEM
5282485
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
EVMPD
SUB01874MIG
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
MERCK INDEX
m4884
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY Merck Index
DRUG BANK
DBSALT002462
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
SMS_ID
100000089139
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
EVMPD
SUB20967
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
EPA CompTox
DTXSID2046911
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
CHEBI
59865
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
RXCUI
221094
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY RxNorm
CAS
87233-62-3
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
USAN
II-46
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
RS_ITEM_NUM
1234806
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
ChEMBL
CHEMBL594
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
NCI_THESAURUS
C61744
Created by admin on Fri Dec 15 15:50:17 UTC 2023 , Edited by admin on Fri Dec 15 15:50:17 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of EMEDASTINE
PARENT (SALT/SOLVATE)
Structure of Fumaric acid
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966